{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:06:13Z","timestamp":1760486773071,"version":"build-2065373602"},"reference-count":125,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,13]]},"DOI":"10.7759\/cureus.94502","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T23:35:27Z","timestamp":1760398527000},"source":"Crossref","is-referenced-by-count":0,"title":["What Has SARS-CoV-2 Taught Us About Evolution?"],"prefix":"10.7759","author":[{"given":"Yingguang","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/J.PLREV.2005.11.002","article-title":"Viral evolution","volume":"3","author":"Manrubia SC","year":"2006","unstructured":"Manrubia SC, L\u00e1zaro E. Viral evolution. Phys Life Rev. 2006, 3:65. 10.1016\/J.PLREV.2005.11.002","journal-title":"Phys Life Rev"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.46234\/ccdcw2021.255","article-title":"GISAID's role in pandemic response","volume":"3","author":"Khare S","year":"2021","unstructured":"Khare S, Gurry C, Freitas L, et al.. GISAID's role in pandemic response. China CDC Wkly. 2021, 3:1049-51. 10.46234\/ccdcw2021.255","journal-title":"China CDC Wkly"},{"key":"ref3","unstructured":"Covariants. SARS-CoV-2 mutations and variants of interest. (2025). Accessed: September 12, 2025: https:\/\/covariants.org\/."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/CCE.0000000000001122","article-title":"COVID-19 across pandemic variant periods: the Severe Acute Respiratory Infection-Preparedness (SARI-PREP) Study","volume":"6","author":"Mukherjee V","year":"2024","unstructured":"Mukherjee V, Postelnicu R, Parker C, et al.. COVID-19 across pandemic variant periods: the Severe Acute Respiratory Infection-Preparedness (SARI-PREP) Study. Crit Care Explor. 2024, 6:e1122. 10.1097\/CCE.0000000000001122","journal-title":"Crit Care Explor"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2022.06.013","article-title":"Temporal trends in clinical characteristics and in-hospital mortality among patients with COVID-19 in Japan for waves 1, 2, and 3: a retrospective cohort study","volume":"28","author":"Endo H","year":"2022","unstructured":"Endo H, Lee K, Ohnuma T, Watanabe S, Fushimi K. Temporal trends in clinical characteristics and in-hospital mortality among patients with COVID-19 in Japan for waves 1, 2, and 3: a retrospective cohort study. J Infect Chemother. 2022, 28:1393-401. 10.1016\/j.jiac.2022.06.013","journal-title":"J Infect Chemother"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12175572","article-title":"Change in the clinical picture of hospitalized patients with COVID-19 between the early and late period of dominance of the Omicron SARS-CoV-2 variant","volume":"12","author":"Flisiak R","year":"2023","unstructured":"Flisiak R, Zar\u0119bska-Michaluk D, Dobrowolska K, et al.. Change in the clinical picture of hospitalized patients with COVID-19 between the early and late period of dominance of the Omicron SARS-CoV-2 variant. J Clin Med. 2023, 12:5572. 10.3390\/jcm12175572","journal-title":"J Clin Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad276","article-title":"Changing severity and epidemiology of adults hospitalized with coronavirus disease 2019 (COVID-19) in the United States after introduction of COVID-19 vaccines, March 2021-August 2022","volume":"77","author":"Kojima N","year":"2023","unstructured":"Kojima N, Adams K, Self WH, et al.. Changing severity and epidemiology of adults hospitalized with coronavirus disease 2019 (COVID-19) in the United States after introduction of COVID-19 vaccines, March 2021-August 2022. Clin Infect Dis. 2023, 77:547-57. 10.1093\/cid\/ciad276","journal-title":"Clin Infect Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.17305\/bb.2025.12537","article-title":"Is SARS-CoV-2 facing constraints in its adaptive evolution?","volume":"25","author":"Liu Y","year":"2025","unstructured":"Liu Y. Is SARS-CoV-2 facing constraints in its adaptive evolution?. Biomol Biomed. 2025, 25:2407-15. 10.17305\/bb.2025.12537","journal-title":"Biomol Biomed"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bty407","article-title":"Nextstrain: real-time tracking of pathogen evolution","volume":"34","author":"Hadfield J","year":"2018","unstructured":"Hadfield J, Megill C, Bell SM, et al.. Nextstrain: real-time tracking of pathogen evolution. Bioinformatics. 2018, 34:4121-3. 10.1093\/bioinformatics\/bty407","journal-title":"Bioinformatics"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2009.06.036","article-title":"Redefining chronic viral infection","volume":"138","author":"Virgin HW","year":"2009","unstructured":"Virgin HW, Wherry EJ, Ahmed R. Redefining chronic viral infection. Cell. 2009, 138:30-50. 10.1016\/j.cell.2009.06.036","journal-title":"Cell"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1960.tb50016.x","article-title":"B virus infection in monkeys","volume":"85","author":"Keeble SA","year":"1960","unstructured":"Keeble SA. B virus infection in monkeys. Ann N Y Acad Sci. 1960, 85:960-9. 10.1111\/j.1749-6632.1960.tb50016.x","journal-title":"Ann N Y Acad Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1172\/JCI33034","article-title":"Understanding the benign nature of SIV infection in natural hosts","volume":"117","author":"Silvestri G","year":"2007","unstructured":"Silvestri G, Paiardini M, Pandrea I, Lederman MM, Sodora DL. Understanding the benign nature of SIV infection in natural hosts. J Clin Invest. 2007, 117:3148-54. 10.1172\/JCI33034","journal-title":"J Clin Invest"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3201\/eid1608.100208","article-title":"Bat coronaviruses and experimental infection of bats, the Philippines","volume":"16","author":"Watanabe S","year":"2010","unstructured":"Watanabe S, Masangkay JS, Nagata N, et al.. Bat coronaviruses and experimental infection of bats, the Philippines. Emerg Infect Dis. 2010, 16:1217-23. 10.3201\/eid1608.100208","journal-title":"Emerg Infect Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s10393-024-01688-5","article-title":"Detection and prevalence of coronaviruses in European bats: a systematic review","volume":"21","author":"Hemnani M","year":"2024","unstructured":"Hemnani M, da Silva PG, Thompson G, Poeta P, Rebelo H, Mesquita JR. Detection and prevalence of coronaviruses in European bats: a systematic review. Ecohealth. 2024, 21:125-40. 10.1007\/s10393-024-01688-5","journal-title":"Ecohealth"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra052211","article-title":"Avian influenza A (H5N1) infection in humans","volume":"353","author":"Beigel JH","year":"2005","unstructured":"Beigel JH, Farrar J, Han AM, et al.. Avian influenza A (H5N1) infection in humans. N Engl J Med. 2005, 353:1374-85. 10.1056\/NEJMra052211","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1080\/20477724.2015.1122852","article-title":"Middle East respiratory syndrome coronavirus (MERS-CoV): animal to human interaction","volume":"109","author":"Omrani AS","year":"2015","unstructured":"Omrani AS, Al-Tawfiq JA, Memish ZA. Middle East respiratory syndrome coronavirus (MERS-CoV): animal to human interaction. Pathog Glob Health. 2015, 109:354-62. 10.1080\/20477724.2015.1122852","journal-title":"Pathog Glob Health"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1128\/MMBR.00004-08","article-title":"Cross-species virus transmission and the emergence of new epidemic diseases","volume":"72","author":"Parrish CR","year":"2008","unstructured":"Parrish CR, Holmes EC, Morens DM, et al.. Cross-species virus transmission and the emergence of new epidemic diseases. Microbiol Mol Biol Rev. 2008, 72:457-70. 10.1128\/MMBR.00004-08","journal-title":"Microbiol Mol Biol Rev"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.epidem.2009.10.003","article-title":"The evolutionary rate dynamically tracks changes in HIV-1 epidemics: application of a simple method for optimizing the evolutionary rate in phylogenetic trees with longitudinal data","volume":"1","author":"Maljkovic Berry I","year":"2009","unstructured":"Maljkovic Berry I, Athreya G, Kothari M, et al.. The evolutionary rate dynamically tracks changes in HIV-1 epidemics: application of a simple method for optimizing the evolutionary rate in phylogenetic trees with longitudinal data. Epidemics. 2009, 1:230-9. 10.1016\/j.epidem.2009.10.003","journal-title":"Epidemics"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/emph\/eoac010","article-title":"Mutation rate of SARS-CoV-2 and emergence of mutators during experimental evolution","volume":"10","author":"Amicone M","year":"2022","unstructured":"Amicone M, Borges V, Alves MJ, et al.. Mutation rate of SARS-CoV-2 and emergence of mutators during experimental evolution. Evol Med Public Health. 2022, 10:142-55. 10.1093\/emph\/eoac010","journal-title":"Evol Med Public Health"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.46922","article-title":"Large, three-generation human families reveal post-zygotic mosaicism and variability in germline mutation accumulation","volume":"8","author":"Sasani TA","year":"2019","unstructured":"Sasani TA, Pedersen BS, Gao Z, Baird L, Przeworski M, Jorde LB, Quinlan AR. Large, three-generation human families reveal post-zygotic mosaicism and variability in germline mutation accumulation. Elife. 2019, 8:10.7554\/eLife.46922","journal-title":"Elife"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-020-03745-y","article-title":"Ultrastructural modifications induced by SARS-CoV-2 in Vero cells: a kinetic analysis of viral factory formation, viral particle morphogenesis and virion release","volume":"78","author":"Eymieux S","year":"2021","unstructured":"Eymieux S, Rouill\u00e9 Y, Terrier O, et al.. Ultrastructural modifications induced by SARS-CoV-2 in Vero cells: a kinetic analysis of viral factory formation, viral particle morphogenesis and virion release. Cell Mol Life Sci. 2021, 78:3565-76. 10.1007\/s00018-020-03745-y","journal-title":"Cell Mol Life Sci"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abm7047","article-title":"Human generation times across the past 250,000 years","volume":"9","author":"Wang RJ","year":"2023","unstructured":"Wang RJ, Al-Saffar SI, Rogers J, Hahn MW. Human generation times across the past 250,000 years. Sci Adv. 2023, 9:eabm7047. 10.1126\/sciadv.abm7047","journal-title":"Sci Adv"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2895-3","article-title":"Spike mutation D614G alters SARS-CoV-2 fitness","volume":"592","author":"Plante JA","year":"2021","unstructured":"Plante JA, Liu Y, Liu J, et al.. Spike mutation D614G alters SARS-CoV-2 fitness. Nature. 2021, 592:116-21. 10.1038\/s41586-020-2895-3","journal-title":"Nature"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2023.116104","article-title":"Fixation and reversion of mutations in the receptor-binding domain of SARS-CoV-2 spike protein","volume":"108","author":"Focosi D","year":"2024","unstructured":"Focosi D, Spezia PG, Maggi F. Fixation and reversion of mutations in the receptor-binding domain of SARS-CoV-2 spike protein. Diagn Microbiol Infect Dis. 2024, 108:116104. 10.1016\/j.diagmicrobio.2023.116104","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.sbi.2018.11.001","article-title":"Structural gymnastics of RAG-mediated DNA cleavage in V(D)J recombination","volume":"53","author":"Ru H","year":"2018","unstructured":"Ru H, Zhang P, Wu H. Structural gymnastics of RAG-mediated DNA cleavage in V(D)J recombination. Curr Opin Struct Biol. 2018, 53:178-86. 10.1016\/j.sbi.2018.11.001","journal-title":"Curr Opin Struct Biol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2012.09.113","article-title":"Genetic variability of glutathione S-transferase enzymes in human populations: functional inter-ethnic differences in detoxification systems","volume":"512","author":"Polimanti R","year":"2013","unstructured":"Polimanti R, Carboni C, Baesso I, Piacentini S, Iorio A, De Stefano GF, Fuciarelli M. Genetic variability of glutathione S-transferase enzymes in human populations: functional inter-ethnic differences in detoxification systems. Gene. 2013, 512:102-7. 10.1016\/j.gene.2012.09.113","journal-title":"Gene"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2015.01.007","article-title":"Epigenetic regulation of drug metabolism and transport","volume":"5","author":"Peng L","year":"2015","unstructured":"Peng L, Zhong X. Epigenetic regulation of drug metabolism and transport. Acta Pharm Sin B. 2015, 5:106-12. 10.1016\/j.apsb.2015.01.007","journal-title":"Acta Pharm Sin B"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1002\/jez.b.22562","article-title":"Dynamics and constraints of enzyme evolution","volume":"322","author":"Kaltenbach M","year":"2014","unstructured":"Kaltenbach M, Tokuriki N. Dynamics and constraints of enzyme evolution. J Exp Zool B Mol Dev Evol. 2014, 322:468-87. 10.1002\/jez.b.22562","journal-title":"J Exp Zool B Mol Dev Evol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2020216118","article-title":"Cross-species recognition of SARS-CoV-2 to bat ACE2","volume":"118","author":"Liu K","year":"2021","unstructured":"Liu K, Tan S, Niu S, et al.. Cross-species recognition of SARS-CoV-2 to bat ACE2. Proc Natl Acad Sci. 2021, 118:10.1073\/pnas.2020216118","journal-title":"Proc Natl Acad Sci"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00608-22","article-title":"Species-specific molecular barriers to SARS-CoV-2 replication in bat cells","volume":"96","author":"Aicher SM","year":"2022","unstructured":"Aicher SM, Streicher F, Chazal M, et al.. Species-specific molecular barriers to SARS-CoV-2 replication in bat cells. J Virol. 2022, 96:e0060822. 10.1128\/jvi.00608-22","journal-title":"J Virol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3390\/v17040507","article-title":"The ACE2 receptor from common vampire bat (Desmodus rotundus) and pallid bat (Antrozous pallidus) support attachment and limited infection of SARS-CoV-2 viruses in cell culture","volume":"17","author":"Bakre A","year":"2025","unstructured":"Bakre A, Sweeney R, Espinoza E, Suarez DL, Kapczynski DR. The ACE2 receptor from common vampire bat (Desmodus rotundus) and pallid bat (Antrozous pallidus) support attachment and limited infection of SARS-CoV-2 viruses in cell culture. Viruses. 2025, 17:507. 10.3390\/v17040507","journal-title":"Viruses"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1111\/resp.14003","article-title":"ACE2 expression is elevated in airway epithelial cells from older and male healthy individuals but reduced in asthma","volume":"26","author":"Wark PA","year":"2021","unstructured":"Wark PA, Pathinayake PS, Kaiko G, et al.. ACE2 expression is elevated in airway epithelial cells from older and male healthy individuals but reduced in asthma. Respirology. 2021, 26:442-51. 10.1111\/resp.14003","journal-title":"Respirology"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2021.2023329","article-title":"SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells","volume":"11","author":"Zhao H","year":"2022","unstructured":"Zhao H, Lu L, Peng Z, et al.. SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells. Emerg Microbes Infect. 2022, 11:277-83. 10.1080\/22221751.2021.2023329","journal-title":"Emerg Microbes Infect"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1128\/msphere.00338-24","article-title":"SARS-CoV-2 Omicron subvariants progressively adapt to human cells with altered host cell entry","volume":"9","author":"Sakurai Y","year":"2024","unstructured":"Sakurai Y, Okada S, Ozeki T, Yoshikawa R, Kinoshita T, Yasuda J. SARS-CoV-2 Omicron subvariants progressively adapt to human cells with altered host cell entry. mSphere. 2024, 9:e0033824. 10.1128\/msphere.00338-24","journal-title":"mSphere"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53033-7","article-title":"Lineage-specific pathogenicity, immune evasion, and virological features of SARS-CoV-2 BA.2.86\/JN.1 and EG.5.1\/HK.3","volume":"15","author":"Liu Y","year":"2024","unstructured":"Liu Y, Zhao X, Shi J, et al.. Lineage-specific pathogenicity, immune evasion, and virological features of SARS-CoV-2 BA.2.86\/JN.1 and EG.5.1\/HK.3. Nat Commun. 2024, 15:8728. 10.1038\/s41467-024-53033-7","journal-title":"Nat Commun"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2020.10.012","article-title":"Recognition of the SARS-CoV-2 receptor binding domain by neutralizing antibodies","volume":"538","author":"Yuan M","year":"2021","unstructured":"Yuan M, Liu H, Wu NC, Wilson IA. Recognition of the SARS-CoV-2 receptor binding domain by neutralizing antibodies. Biochem Biophys Res Commun. 2021, 538:192-203. 10.1016\/j.bbrc.2020.10.012","journal-title":"Biochem Biophys Res Commun"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109604","article-title":"Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals","volume":"36","author":"Chen EC","year":"2021","unstructured":"Chen EC, Gilchuk P, Zost SJ, et al.. Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals. Cell Rep. 2021, 36:109604. 10.1016\/j.celrep.2021.109604","journal-title":"Cell Rep"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1126\/science.abf9302","article-title":"Prospective mapping of viral mutations that escape antibodies used to treat COVID-19","volume":"371","author":"Starr TN","year":"2021","unstructured":"Starr TN, Greaney AJ, Addetia A, et al.. Prospective mapping of viral mutations that escape antibodies used to treat COVID-19. Science. 2021, 371:850-4. 10.1126\/science.abf9302","journal-title":"Science"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2021.02.003","article-title":"Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies","volume":"29","author":"Greaney AJ","year":"2021","unstructured":"Greaney AJ, Loes AN, Crawford KH, Starr TN, Malone KD, Chu HY, Bloom JD. Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies. Cell Host Microbe. 2021, 29:463-76.e6. 10.1016\/j.chom.2021.02.003","journal-title":"Cell Host Microbe"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19808-4","article-title":"SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity","volume":"11","author":"Zhang L","year":"2020","unstructured":"Zhang L, Jackson CB, Mou H, et al.. SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity. Nat Commun. 2020, 11:6013. 10.1038\/s41467-020-19808-4","journal-title":"Nat Commun"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1126\/science.abf2303","article-title":"Structural impact on SARS-CoV-2 spike protein by D614G substitution","volume":"372","author":"Zhang J","year":"2021","unstructured":"Zhang J, Cai Y, Xiao T, et al.. Structural impact on SARS-CoV-2 spike protein by D614G substitution. Science. 2021, 372:525-30. 10.1126\/science.abf2303","journal-title":"Science"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-023-03070-8","article-title":"Assessing changes in incubation period, serial interval, and generation time of SARS-CoV-2 variants of concern: a systematic review and meta-analysis","volume":"21","author":"Xu X","year":"2023","unstructured":"Xu X, Wu Y, Kummer AG, et al.. Assessing changes in incubation period, serial interval, and generation time of SARS-CoV-2 variants of concern: a systematic review and meta-analysis. BMC Med. 2023, 21:374. 10.1186\/s12916-023-03070-8","journal-title":"BMC Med"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2024.106121","article-title":"Molecular insights into the adaptive evolution of SARS-CoV-2 spike protein","volume":"88","author":"Yao Z","year":"2024","unstructured":"Yao Z, Zhang L, Duan Y, Tang X, Lu J. Molecular insights into the adaptive evolution of SARS-CoV-2 spike protein. J Infect. 2024, 88:106121. 10.1016\/j.jinf.2024.106121","journal-title":"J Infect"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1534\/genetics.114.165720","article-title":"Pleiotropic mutations are subject to strong stabilizing selection","volume":"197","author":"McGuigan K","year":"2014","unstructured":"McGuigan K, Collet JM, Allen SL, Chenoweth SF, Blows MW. Pleiotropic mutations are subject to strong stabilizing selection. Genetics. 2014, 197:1051-62. 10.1534\/genetics.114.165720","journal-title":"Genetics"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1098\/rspb.2003.2635","article-title":"Two steps forward, one step back: the pleiotropic effects of favoured alleles","volume":"271","author":"Otto SP","year":"2004","unstructured":"Otto SP. Two steps forward, one step back: the pleiotropic effects of favoured alleles. Proc Biol Sci. 2004, 271:705-14. 10.1098\/rspb.2003.2635","journal-title":"Proc Biol Sci"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1038\/s44318-024-00062-z","article-title":"Key mechanistic features of the trade-off between antibody escape and host cell binding in the SARS-CoV-2 Omicron variant spike proteins","volume":"43","author":"Li W","year":"2024","unstructured":"Li W, Xu Z, Niu T, et al.. Key mechanistic features of the trade-off between antibody escape and host cell binding in the SARS-CoV-2 Omicron variant spike proteins. EMBO J. 2024, 43:1484-98. 10.1038\/s44318-024-00062-z","journal-title":"EMBO J"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.3390\/v16091458","article-title":"AlphaFold2 modeling and molecular dynamics simulations of the conformational ensembles for the SARS-CoV-2 spike Omicron JN.1, KP.2 and KP.3 variants: mutational profiling of binding energetics reveals epistatic drivers of the ACE2 affinity and escape hotspots of antibody resistance","volume":"16","author":"Raisinghani N","year":"2024","unstructured":"Raisinghani N, Alshahrani M, Gupta G, Verkhivker G. AlphaFold2 modeling and molecular dynamics simulations of the conformational ensembles for the SARS-CoV-2 spike Omicron JN.1, KP.2 and KP.3 variants: mutational profiling of binding energetics reveals epistatic drivers of the ACE2 affinity and escape hotspots of antibody resistance. Viruses. 2024, 16:1458. 10.3390\/v16091458","journal-title":"Viruses"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-021-00954-4","article-title":"SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution","volume":"6","author":"Zahradn\u00edk J","year":"2021","unstructured":"Zahradn\u00edk J, Marciano S, Shemesh M, et al.. SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution. Nat Microbiol. 2021, 6:1188-98. 10.1038\/s41564-021-00954-4","journal-title":"Nat Microbiol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.825256","article-title":"SARS-CoV-2 variants of concern and variants of interest receptor binding domain mutations and virus infectivity","volume":"13","author":"Liu H","year":"2022","unstructured":"Liu H, Wei P, Kappler JW, Marrack P, Zhang G. SARS-CoV-2 variants of concern and variants of interest receptor binding domain mutations and virus infectivity. Front Immunol. 2022, 13:825256. 10.3389\/fimmu.2022.825256","journal-title":"Front Immunol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51973-8","article-title":"Structural basis for the evolution and antibody evasion of SARS-CoV-2 BA.2.86 and JN.1 subvariants","volume":"15","author":"Yang H","year":"2024","unstructured":"Yang H, Guo H, Wang A, et al.. Structural basis for the evolution and antibody evasion of SARS-CoV-2 BA.2.86 and JN.1 subvariants. Nat Commun. 2024, 15:7715. 10.1038\/s41467-024-51973-8","journal-title":"Nat Commun"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00744-2","article-title":"Fast evolution of SARS-CoV-2 BA.2.86 to JN.1 under heavy immune pressure","volume":"24","author":"Yang S","year":"2024","unstructured":"Yang S, Yu Y, Xu Y, et al.. Fast evolution of SARS-CoV-2 BA.2.86 to JN.1 under heavy immune pressure. Lancet Infect Dis . 2024, 24:70-2. 10.1016\/S1473-3099(23)00744-2","journal-title":"Lancet Infect Dis"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1016\/J.MRAN.2023.100278","article-title":"In silico binding affinity of the spike protein with ACE2 and the relative evolutionary distance of S gene may be potential factors rapidly obtained for the initial risk of SARS-CoV-2","volume":"25","author":"Sugano A","year":"2023","unstructured":"Sugano A, Murakami J, Kataguchi H, et al.. In silico binding affinity of the spike protein with ACE2 and the relative evolutionary distance of S gene may be potential factors rapidly obtained for the initial risk of SARS-CoV-2. Microb Risk Anal. 2023, 25:100278. 10.1016\/J.MRAN.2023.100278","journal-title":"Microb Risk Anal"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-023-01769-3","article-title":"Outbreak.info genomic reports: scalable and dynamic surveillance of SARS-CoV-2 variants and mutations","volume":"20","author":"Gangavarapu K","year":"2023","unstructured":"Gangavarapu K, Latif AA, Mullen JL, et al.. Outbreak.info genomic reports: scalable and dynamic surveillance of SARS-CoV-2 variants and mutations. Nat Methods. 2023, 20:512-22. 10.1038\/s41592-023-01769-3","journal-title":"Nat Methods"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1126\/science.1203799","article-title":"Diminishing returns epistasis among beneficial mutations decelerates adaptation","volume":"332","author":"Chou HH","year":"2011","unstructured":"Chou HH, Chiu HC, Delaney NF, Segr\u00e8 D, Marx CJ. Diminishing returns epistasis among beneficial mutations decelerates adaptation. Science. 2011, 332:1190-2. 10.1126\/science.1203799","journal-title":"Science"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1126\/science.1203801","article-title":"Negative epistasis between beneficial mutations in an evolving bacterial population","volume":"332","author":"Khan AI","year":"2011","unstructured":"Khan AI, Dinh DM, Schneider D, Lenski RE, Cooper TF. Negative epistasis between beneficial mutations in an evolving bacterial population. Science. 2011, 332:1193-6. 10.1126\/science.1203801","journal-title":"Science"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1126\/science.1123539","article-title":"Darwinian evolution can follow only very few mutational paths to fitter proteins","volume":"312","author":"Weinreich DM","year":"2006","unstructured":"Weinreich DM, Delaney NF, Depristo MA, Hartl DL. Darwinian evolution can follow only very few mutational paths to fitter proteins. Science. 2006, 312:111-4. 10.1126\/science.1123539","journal-title":"Science"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(21)00068-9","article-title":"SARS-CoV-2 spike E484K mutation reduces antibody neutralisation","volume":"2","author":"Jangra S","year":"2021","unstructured":"Jangra S, Ye C, Rathnasinghe R, et al.. SARS-CoV-2 spike E484K mutation reduces antibody neutralisation. Lancet Microbe. 2021, 2:e283-4. 10.1016\/S2666-5247(21)00068-9","journal-title":"Lancet Microbe"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.70658","article-title":"Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics","volume":"10","author":"Barton MI","year":"2021","unstructured":"Barton MI, MacGowan SA, Kutuzov MA, Dushek O, Barton GJ, van der Merwe PA. Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics. Elife. 2021, 10:10.7554\/eLife.70658","journal-title":"Elife"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1515\/hmbci-2023-0088","article-title":"JN.1 variant in enduring COVID-19 pandemic: is it a variety of interest (VoI) or variety of concern (VoC)?","volume":"45","author":"Kamble P","year":"2024","unstructured":"Kamble P, Daulatabad V, Singhal A, Ahmed ZS, Choubey A, Bhargava S, John NA. JN.1 variant in enduring COVID-19 pandemic: is it a variety of interest (VoI) or variety of concern (VoC)?. Horm Mol Biol Clin Investig. 2024, 45:49-53. 10.1515\/hmbci-2023-0088","journal-title":"Horm Mol Biol Clin Investig"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1126\/science.abo7896","article-title":"Shifting mutational constraints in the SARS-CoV-2 receptor-binding domain during viral evolution","volume":"377","author":"Starr TN","year":"2022","unstructured":"Starr TN, Greaney AJ, Hannon WW, et al.. Shifting mutational constraints in the SARS-CoV-2 receptor-binding domain during viral evolution. Science. 2022, 377:420-4. 10.1126\/science.abo7896","journal-title":"Science"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03908-2","article-title":"Emergence and expansion of SARS-CoV-2 B.1.526 after identification in New York","volume":"597","author":"Annavajhala MK","year":"2021","unstructured":"Annavajhala MK, Mohri H, Wang P, et al.. Emergence and expansion of SARS-CoV-2 B.1.526 after identification in New York. Nature. 2021, 597:703-8. 10.1038\/s41586-021-03908-2","journal-title":"Nature"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2022.09.015","article-title":"Evasion of neutralizing antibody responses by the SARS-CoV-2 BA.2.75 variant","volume":"30","author":"Qu P","year":"2022","unstructured":"Qu P, Evans JP, Zheng YM, et al.. Evasion of neutralizing antibody responses by the SARS-CoV-2 BA.2.75 variant. Cell Host Microbe. 2022, 30:1518-26.e4. 10.1016\/j.chom.2022.09.015","journal-title":"Cell Host Microbe"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jpcb.3c06270","article-title":"SARS-CoV-2 Omicron subvariants do not differ much in binding affinity to human ACE2: a molecular dynamics study","volume":"128","author":"Nguyen HL","year":"2024","unstructured":"Nguyen HL, Nguyen TQ, Li MS. SARS-CoV-2 Omicron subvariants do not differ much in binding affinity to human ACE2: a molecular dynamics study. J Phys Chem B. 2024, 128:3340-9. 10.1021\/acs.jpcb.3c06270","journal-title":"J Phys Chem B"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2022.09.018","article-title":"Characterization of the enhanced infectivity and antibody evasion of Omicron BA.2.75","volume":"30","author":"Cao Y","year":"2022","unstructured":"Cao Y, Song W, Wang L, et al.. Characterization of the enhanced infectivity and antibody evasion of Omicron BA.2.75. Cell Host Microbe. 2022, 30:1527-39.e5. 10.1016\/j.chom.2022.09.018","journal-title":"Cell Host Microbe"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111903","article-title":"A delicate balance between antibody evasion and ACE2 affinity for Omicron BA.2.75","volume":"42","author":"Huo J","year":"2023","unstructured":"Huo J, Dijokaite-Guraliuc A, Liu C, et al.. A delicate balance between antibody evasion and ACE2 affinity for Omicron BA.2.75. Cell Rep. 2023, 42:111903. 10.1016\/j.celrep.2022.111903","journal-title":"Cell Rep"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.110156","article-title":"Structural analysis of receptor binding domain mutations in SARS-CoV-2 variants of concern that modulate ACE2 and antibody binding","volume":"37","author":"Mannar D","year":"2021","unstructured":"Mannar D, Saville JW, Zhu X, et al.. Structural analysis of receptor binding domain mutations in SARS-CoV-2 variants of concern that modulate ACE2 and antibody binding. Cell Rep. 2021, 37:110156. 10.1016\/j.celrep.2021.110156","journal-title":"Cell Rep"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28528-w","article-title":"Structural basis for SARS-CoV-2 Delta variant recognition of ACE2 receptor and broadly neutralizing antibodies","volume":"13","author":"Wang Y","year":"2022","unstructured":"Wang Y, Liu C, Zhang C, et al.. Structural basis for SARS-CoV-2 Delta variant recognition of ACE2 receptor and broadly neutralizing antibodies. Nat Commun. 2022, 13:871. 10.1038\/s41467-022-28528-w","journal-title":"Nat Commun"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1093\/ve\/veac113","article-title":"Contributions of adaptation and purifying selection to SARS-CoV-2 evolution","volume":"8","author":"Neher RA","year":"2022","unstructured":"Neher RA. Contributions of adaptation and purifying selection to SARS-CoV-2 evolution. Virus Evol. 2022, 8:veac113. 10.1093\/ve\/veac113","journal-title":"Virus Evol"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00921-21","article-title":"Acquisition of the L452R mutation in the ACE2-binding interface of spike protein triggers recent massive expansion of SARS-CoV-2 variants","volume":"59","author":"Tchesnokova V","year":"2021","unstructured":"Tchesnokova V, Kulasekara H, Larson L, et al.. Acquisition of the L452R mutation in the ACE2-binding interface of spike protein triggers recent massive expansion of SARS-CoV-2 variants. J Clin Microbiol. 2021, 59:e0092121. 10.1128\/JCM.00921-21","journal-title":"J Clin Microbiol"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.3390\/biom12121742","article-title":"SARS-CoV-2 delta variant: interplay between individual mutations and their allosteric synergy","volume":"12","author":"Chan KC","year":"2022","unstructured":"Chan KC, Song Y, Xu Z, Shang C, Zhou R. SARS-CoV-2 delta variant: interplay between individual mutations and their allosteric synergy. Biomolecules. 2022, 12:1742. 10.3390\/biom12121742","journal-title":"Biomolecules"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-024-03355-y","article-title":"Real-time identification of epistatic interactions in SARS-CoV-2 from large genome collections","volume":"25","author":"Innocenti G","year":"2024","unstructured":"Innocenti G, Obara M, Costa B, et al.. Real-time identification of epistatic interactions in SARS-CoV-2 from large genome collections. Genome Biol. 2024, 25:228. 10.1186\/s13059-024-03355-y","journal-title":"Genome Biol"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbj.2023.02.019","article-title":"Reversal of the unique Q493R mutation increases the affinity of Omicron S1-RBD for ACE2","volume":"21","author":"Philip AM","year":"2023","unstructured":"Philip AM, Ahmed WS, Biswas KH. Reversal of the unique Q493R mutation increases the affinity of Omicron S1-RBD for ACE2. Comput Struct Biotechnol J. 2023, 21:1966-77. 10.1016\/j.csbj.2023.02.019","journal-title":"Comput Struct Biotechnol J"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05053-w","article-title":"Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5","volume":"608","author":"Wang Q","year":"2022","unstructured":"Wang Q, Guo Y, Iketani S, et al.. Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5. Nature. 2022, 608:603-8. 10.1038\/s41586-022-05053-w","journal-title":"Nature"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1093\/ve\/veae067","article-title":"Deep mutational scanning of SARS-CoV-2 Omicron BA.2.86 and epistatic emergence of the KP.3 variant","volume":"10","author":"Taylor AL","year":"2024","unstructured":"Taylor AL, Starr TN. Deep mutational scanning of SARS-CoV-2 Omicron BA.2.86 and epistatic emergence of the KP.3 variant. Virus Evol. 2024, 10:veae067. 10.1093\/ve\/veae067","journal-title":"Virus Evol"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1038\/s41421-024-00752-2","article-title":"Structural and molecular basis of the epistasis effect in enhanced affinity between SARS-CoV-2 KP.3 and ACE2","volume":"10","author":"Feng L","year":"2024","unstructured":"Feng L, Sun Z, Zhang Y, et al.. Structural and molecular basis of the epistasis effect in enhanced affinity between SARS-CoV-2 KP.3 and ACE2. Cell Discov. 2024, 10:123. 10.1038\/s41421-024-00752-2","journal-title":"Cell Discov"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1011868","article-title":"Convergent evolution of SARS-CoV-2 XBB lineages on receptor-binding domain 455-456 synergistically enhances antibody evasion and ACE2 binding","volume":"19","author":"Jian F","year":"2023","unstructured":"Jian F, Feng L, Yang S, et al.. Convergent evolution of SARS-CoV-2 XBB lineages on receptor-binding domain 455-456 synergistically enhances antibody evasion and ACE2 binding. PLoS Pathog. 2023, 19:e1011868. 10.1371\/journal.ppat.1011868","journal-title":"PLoS Pathog"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkq901","article-title":"ViralZone: a knowledge resource to understand virus diversity","volume":"39","author":"Hulo C","year":"2011","unstructured":"Hulo C, de Castro E, Masson P, Bougueleret L, Bairoch A, Xenarios I, Le Mercier P. ViralZone: a knowledge resource to understand virus diversity. Nucleic Acids Res. 2011, 39:D576-82. 10.1093\/nar\/gkq901","journal-title":"Nucleic Acids Res"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.12.046","article-title":"SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses","volume":"185","author":"Dejnirattisai W","year":"2022","unstructured":"Dejnirattisai W, Huo J, Zhou D, et al.. SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses. Cell. 2022, 185:467-84.e15. 10.1016\/j.cell.2021.12.046","journal-title":"Cell"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2024.2402880","article-title":"Recurrent SARS-CoV-2 spike mutations confer growth advantages to select JN.1 sublineages","volume":"13","author":"Wang Q","year":"2024","unstructured":"Wang Q, Mellis IA, Ho J, et al.. Recurrent SARS-CoV-2 spike mutations confer growth advantages to select JN.1 sublineages. Emerg Microbes Infect. 2024, 13:2402880. 10.1080\/22221751.2024.2402880","journal-title":"Emerg Microbes Infect"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-10097-z","article-title":"Rapid evolution of SARS-CoV-2 challenges human defenses","volume":"12","author":"Duarte CM","year":"2022","unstructured":"Duarte CM, Ketcheson DI, Egu\u00edluz VM, et al.. Rapid evolution of SARS-CoV-2 challenges human defenses. Sci Rep. 2022, 12:6457. 10.1038\/s41598-022-10097-z","journal-title":"Sci Rep"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1016\/0027-5107(64)90047-8","article-title":"The relation of recombination to mutational advance","volume":"1","author":"Muller HJ","year":"1964","unstructured":"Muller HJ. The relation of recombination to mutational advance. Mutat Res Fundam Mol Mech Mutagen. 1964, 1:2-9. 10.1016\/0027-5107(64)90047-8","journal-title":"Mutat Res Fundam Mol Mech Mutagen"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1038\/348454a0","article-title":"Fitness of RNA virus decreased by Muller's ratchet","volume":"348","author":"Chao L","year":"1990","unstructured":"Chao L. Fitness of RNA virus decreased by Muller's ratchet. Nature. 1990, 348:454-5. 10.1038\/348454a0","journal-title":"Nature"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.2.906","article-title":"Muller's ratchet decreases fitness of a DNA-based microbe","volume":"93","author":"Andersson DI","year":"1996","unstructured":"Andersson DI, Hughes D. Muller's ratchet decreases fitness of a DNA-based microbe. Proc Natl Acad Sci. 1996, 93:906-7. 10.1073\/pnas.93.2.906","journal-title":"Proc Natl Acad Sci"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028889","article-title":"Differential trends in the codon usage patterns in HIV-1 genes","volume":"6","author":"Pandit A","year":"2011","unstructured":"Pandit A, Sinha S. Differential trends in the codon usage patterns in HIV-1 genes. PLoS One. 2011, 6:e28889. 10.1371\/journal.pone.0028889","journal-title":"PLoS One"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4682-9-42","article-title":"A new look at an old virus: patterns of mutation accumulation in the human H1N1 influenza virus since 1918","volume":"9","author":"Carter RW","year":"2012","unstructured":"Carter RW, Sanford JC. A new look at an old virus: patterns of mutation accumulation in the human H1N1 influenza virus since 1918. Theor Biol Med Model. 2012, 9:42. 10.1186\/1742-4682-9-42","journal-title":"Theor Biol Med Model"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.3390\/v15081660","article-title":"SARS-CoV-2 recombination and coinfection events identified in clinical samples in Russia","volume":"15","author":"Chernyaeva EN","year":"2023","unstructured":"Chernyaeva EN, Ayginin AA, Kosenkov AV, et al.. SARS-CoV-2 recombination and coinfection events identified in clinical samples in Russia. Viruses. 2023, 15:1660. 10.3390\/v15081660","journal-title":"Viruses"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1093\/ve\/vead055","article-title":"Fitness effects of\u00a0mutations to SARS-CoV-2 proteins","volume":"9","author":"Bloom JD","year":"2023","unstructured":"Bloom JD, Neher RA. Fitness effects of\u00a0mutations to SARS-CoV-2 proteins. Virus Evol. 2023, 9:vead055. 10.1093\/ve\/vead055","journal-title":"Virus Evol"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.21037\/jlpm-22-17","article-title":"The landscape of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genomic mutations","volume":"7","author":"Lippi G","year":"2022","unstructured":"Lippi G, Henry BM. The landscape of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genomic mutations. J Lab Precis Med. 2022, 7:jlpm-22-17. 10.21037\/jlpm-22-17","journal-title":"J Lab Precis Med"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2204717119","article-title":"SARS-CoV-2 variant spike and accessory gene mutations alter pathogenesis","volume":"119","author":"McGrath ME","year":"2022","unstructured":"McGrath ME, Xue Y, Dillen C, et al.. SARS-CoV-2 variant spike and accessory gene mutations alter pathogenesis. Proc Natl Acad Sci. 2022, 119:e2204717119. 10.1073\/pnas.2204717119","journal-title":"Proc Natl Acad Sci"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02654-23","article-title":"Analysis of SARS-CoV-2 genome evolutionary patterns","volume":"12","author":"Gupta S","year":"2024","unstructured":"Gupta S, Gupta D, Bhatnagar S. Analysis of SARS-CoV-2 genome evolutionary patterns. Microbiol Spectr. 2024, 12:e0265423. 10.1128\/spectrum.02654-23","journal-title":"Microbiol Spectr"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-021-00658-z","article-title":"Mutational spectrum of SARS-CoV-2 during the global pandemic","volume":"53","author":"Yi K","year":"2021","unstructured":"Yi K, Kim SY, Bleazard T, Kim T, Youk J, Ju YS. Mutational spectrum of SARS-CoV-2 during the global pandemic. Exp Mol Med. 2021, 53:1229-37. 10.1038\/s12276-021-00658-z","journal-title":"Exp Mol Med"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2024.106150","article-title":"Role of SARS-CoV-2 mutations in the evolution of the COVID-19 pandemic","volume":"88","author":"Colson P","year":"2024","unstructured":"Colson P, Chaudet H, Delerce J, et al.. Role of SARS-CoV-2 mutations in the evolution of the COVID-19 pandemic. J Infect. 2024, 88:106150. 10.1016\/j.jinf.2024.106150","journal-title":"J Infect"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1186\/s43088-021-00102-1","article-title":"Mutational hotspots and conserved domains of SARS-CoV-2 genome in African population","volume":"10","author":"Omotoso OE","year":"2021","unstructured":"Omotoso OE, Babalola AD, Matareek A. Mutational hotspots and conserved domains of SARS-CoV-2 genome in African population. Beni Suef Univ J Basic Appl Sci. 2021, 10:11. 10.1186\/s43088-021-00102-1","journal-title":"Beni Suef Univ J Basic Appl Sci"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2025.112974","article-title":"Mutation T9I in envelope confers autophagy resistance to SARS-CoV-2 Omicron","volume":"28","author":"Klute S","year":"2025","unstructured":"Klute S, Nchioua R, Cordsmeier A, et al.. Mutation T9I in envelope confers autophagy resistance to SARS-CoV-2 Omicron. iScience. 2025, 28:112974. 10.1016\/j.isci.2025.112974","journal-title":"iScience"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28630","article-title":"Genetic variety of ORF3a shapes SARS-CoV-2 fitness through modulation of lipid droplet","volume":"95","author":"Wang W","year":"2023","unstructured":"Wang W, Qu Y, Wang X, et al.. Genetic variety of ORF3a shapes SARS-CoV-2 fitness through modulation of lipid droplet. J Med Virol. 2023, 95:e28630. 10.1002\/jmv.28630","journal-title":"J Med Virol"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-59475-x","article-title":"SARS-CoV-2 ORF3a drives dynamic dense body formation for optimal viral infectivity","volume":"16","author":"Hartmann S","year":"2025","unstructured":"Hartmann S, Radochonski L, Ye C, Martinez-Sobrido L, Chen J. SARS-CoV-2 ORF3a drives dynamic dense body formation for optimal viral infectivity. Nat Commun. 2025, 16:4393. 10.1038\/s41467-025-59475-x","journal-title":"Nat Commun"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1220306","article-title":"SARS-CoV-2 accessory proteins involvement in inflammatory and profibrotic processes through IL11 signaling","volume":"14","author":"L\u00f3pez-Ayll\u00f3n BD","year":"2023","unstructured":"L\u00f3pez-Ayll\u00f3n BD, de Lucas-Rius A, Mendoza-Garc\u00eda L, et al.. SARS-CoV-2 accessory proteins involvement in inflammatory and profibrotic processes through IL11 signaling. Front Immunol. 2023, 14:1220306. 10.3389\/fimmu.2023.1220306","journal-title":"Front Immunol"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12080887","article-title":"Subsequent waves of convergent evolution in SARS-CoV-2 genes and proteins","volume":"12","author":"Focosi D","year":"2024","unstructured":"Focosi D, Spezia PG, Maggi F. Subsequent waves of convergent evolution in SARS-CoV-2 genes and proteins. Vaccines (Basel). 2024, 12:887. 10.3390\/vaccines12080887","journal-title":"Vaccines (Basel)"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.3390\/v15020522","article-title":"Persistence of a frameshifting deletion in SARS-CoV-2 ORF7a for the duration of a major outbreak","volume":"15","author":"Foster CS","year":"2023","unstructured":"Foster CS, Bull RA, Tedla N, et al.. Persistence of a frameshifting deletion in SARS-CoV-2 ORF7a for the duration of a major outbreak. Viruses. 2023, 15:522. 10.3390\/v15020522","journal-title":"Viruses"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0263563","article-title":"Consecutive deletions in a unique Uruguayan SARS-CoV-2 lineage evidence the genetic variability potential of accessory genes","volume":"17","author":"Panzera Y","year":"2022","unstructured":"Panzera Y, Calleros L, Go\u00f1i N, et al.. Consecutive deletions in a unique Uruguayan SARS-CoV-2 lineage evidence the genetic variability potential of accessory genes. PLoS One. 2022, 17:e0263563. 10.1371\/journal.pone.0263563","journal-title":"PLoS One"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26125778","article-title":"The recurring loss of ORF8 secretion in dominant SARS-CoV-2 variants","volume":"26","author":"Lam JY","year":"2025","unstructured":"Lam JY, Kok KH. The recurring loss of ORF8 secretion in dominant SARS-CoV-2 variants. Int J Mol Sci. 2025, 26:5578. 10.3390\/ijms26125778","journal-title":"Int J Mol Sci"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2024202118","article-title":"The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-\u0399","volume":"118","author":"Zhang Y","year":"2021","unstructured":"Zhang Y, Chen Y, Li Y, et al.. The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-\u0399. Proc Natl Acad Sci. 2021, 118:e2024202118. 10.1073\/pnas.2024202118","journal-title":"Proc Natl Acad Sci"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.3390\/v15040871","article-title":"SARS-CoV-2 ORF8: a rapidly evolving immune and viral modulator in COVID-19","volume":"15","author":"Arduini A","year":"2023","unstructured":"Arduini A, Laprise F, Liang C. SARS-CoV-2 ORF8: a rapidly evolving immune and viral modulator in COVID-19. Viruses. 2023, 15:871. 10.3390\/v15040871","journal-title":"Viruses"},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47599-5","article-title":"Positive selection underlies repeated knockout of ORF8 in SARS-CoV-2 evolution","volume":"15","author":"Wagner C","year":"2024","unstructured":"Wagner C, Kistler KE, Perchetti GA, et al.. Positive selection underlies repeated knockout of ORF8 in SARS-CoV-2 evolution. Nat Commun. 2024, 15:3207. 10.1038\/s41467-024-47599-5","journal-title":"Nat Commun"},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.29146","article-title":"The return of the \"Mistigri\" (virus adaptative gain by gene loss) through the SARS-CoV-2 XBB.1.5 chimera that predominated in 2023","volume":"95","author":"Colson P","year":"2023","unstructured":"Colson P, Delerce J, Fantini J, Pontarotti P, La Scola B, Raoult D. The return of the \"Mistigri\" (virus adaptative gain by gene loss) through the SARS-CoV-2 XBB.1.5 chimera that predominated in 2023. J Med Virol. 2023, 95:e29146. 10.1002\/jmv.29146","journal-title":"J Med Virol"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.1007\/s00430-022-00729-6","article-title":"Molecular variants of SARS-CoV-2: antigenic properties and current vaccine efficacy","volume":"211","author":"Rayati Damavandi A","year":"2022","unstructured":"Rayati Damavandi A, Dowran R, Al Sharif S, Kashanchi F, Jafari R. Molecular variants of SARS-CoV-2: antigenic properties and current vaccine efficacy. Med Microbiol Immunol. 2022, 211:79-103. 10.1007\/s00430-022-00729-6","journal-title":"Med Microbiol Immunol"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(02)00665-7","article-title":"Microbial minimalism","volume":"108","author":"Moran NA","year":"2002","unstructured":"Moran NA. Microbial minimalism. Cell. 2002, 108:583-6. 10.1016\/S0092-8674(02)00665-7","journal-title":"Cell"},{"key":"ref108","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-72-5-1031","article-title":"Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence","volume":"72 ( Pt 5)","author":"Meyer H","year":"1991","unstructured":"Meyer H, Sutter G, Mayr A. Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence. J Gen Virol. 1991, 72 ( Pt 5):1031-8. 10.1099\/0022-1317-72-5-1031","journal-title":"J Gen Virol"},{"key":"ref109","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkaf503","article-title":"The mutation rate of SARS-CoV-2 is highly variable between sites and is influenced by sequence context, genomic region, and RNA structure","volume":"53","author":"Haddox HK","year":"2025","unstructured":"Haddox HK, Angehrn G, Sesta L, et al.. The mutation rate of SARS-CoV-2 is highly variable between sites and is influenced by sequence context, genomic region, and RNA structure. Nucleic Acids Res. 2025, 53:gkaf503. 10.1093\/nar\/gkaf503","journal-title":"Nucleic Acids Res"},{"key":"ref110","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2022.198966","article-title":"Natural selection pressure exerted on \"Silent\" mutations during the evolution of SARS-CoV-2: evidence from codon usage and RNA structure","volume":"323","author":"Bai H","year":"2023","unstructured":"Bai H, Ata G, Sun Q, Rahman SU, Tao S. Natural selection pressure exerted on \"Silent\" mutations during the evolution of SARS-CoV-2: evidence from codon usage and RNA structure. Virus Res. 2023, 323:198966. 10.1016\/j.virusres.2022.198966","journal-title":"Virus Res"},{"key":"ref111","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-023-01982-8","article-title":"Analysis of 3.5 million SARS-CoV-2 sequences reveals unique mutational trends with consistent nucleotide and codon frequencies","volume":"20","author":"Fumagalli SE","year":"2023","unstructured":"Fumagalli SE, Padhiar NH, Meyer D, et al.. Analysis of 3.5 million SARS-CoV-2 sequences reveals unique mutational trends with consistent nucleotide and codon frequencies. Virol J. 2023, 20:31. 10.1186\/s12985-023-01982-8","journal-title":"Virol J"},{"key":"ref112","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbj.2025.05.021","article-title":"Over time analysis of the codon usage of SARS-CoV-2 and its variants","volume":"27","author":"Davidson A","year":"2025","unstructured":"Davidson A, Parr M, Totzeck F, Churkin A, Barash D, Frishman D, Tuller T. Over time analysis of the codon usage of SARS-CoV-2 and its variants. Comput Struct Biotechnol J. 2025, 27:2034-50. 10.1016\/j.csbj.2025.05.021","journal-title":"Comput Struct Biotechnol J"},{"key":"ref113","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2022.01.011","article-title":"Analysis of SARS-CoV-2 synonymous codon usage evolution throughout the COVID-19 pandemic","volume":"568","author":"Mogro EG","year":"2022","unstructured":"Mogro EG, Bottero D, Lozano MJ. Analysis of SARS-CoV-2 synonymous codon usage evolution throughout the COVID-19 pandemic. Virology. 2022, 568:56-71. 10.1016\/j.virol.2022.01.011","journal-title":"Virology"},{"key":"ref114","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202205445","article-title":"Optimization and deoptimization of codons in SARS-CoV-2 and related implications for vaccine development","volume":"10","author":"Wu X","year":"2023","unstructured":"Wu X, Shan KJ, Zan F, Tang X, Qian Z, Lu J. Optimization and deoptimization of codons in SARS-CoV-2 and related implications for vaccine development. Adv Sci (Weinh). 2023, 10:e2205445. 10.1002\/advs.202205445","journal-title":"Adv Sci (Weinh)"},{"key":"ref115","doi-asserted-by":"publisher","DOI":"10.31083\/j.fbl2701013","article-title":"Temporal evolution and adaptation of SARS-CoV-2 codon usage","volume":"27","author":"Posani E","year":"2022","unstructured":"Posani E, Dilucca M, Forcelloni S, Pavlopoulou A, Georgakilas AG, Giansanti A. Temporal evolution and adaptation of SARS-CoV-2 codon usage. Front Biosci (Landmark Ed). 2022, 27:13. 10.31083\/j.fbl2701013","journal-title":"Front Biosci (Landmark Ed)"},{"key":"ref116","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2021.104736","article-title":"Codon usage analysis of zoonotic coronaviruses reveals lower adaptation to humans by SARS-CoV-2","volume":"89","author":"Huang W","year":"2021","unstructured":"Huang W, Guo Y, Li N, Feng Y, Xiao L. Codon usage analysis of zoonotic coronaviruses reveals lower adaptation to humans by SARS-CoV-2. Infect Genet Evol. 2021, 89:104736. 10.1016\/j.meegid.2021.104736","journal-title":"Infect Genet Evol"},{"key":"ref117","doi-asserted-by":"publisher","DOI":"10.1093\/ve\/veae115","article-title":"SARS-CoV-2 CoCoPUTs: analyzing GISAID and NCBI data to obtain codon statistics, mutations, and free energy over a multiyear period","volume":"11","author":"Padhiar NH","year":"2025","unstructured":"Padhiar NH, Ghazanchyan T, Fumagalli SE, et al.. SARS-CoV-2 CoCoPUTs: analyzing GISAID and NCBI data to obtain codon statistics, mutations, and free energy over a multiyear period. Virus Evol. 2025, 11:veae115. 10.1093\/ve\/veae115","journal-title":"Virus Evol"},{"key":"ref118","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.106210","article-title":"Genomic diversity of SARS-CoV-2 can be accelerated by mutations in the nsp14 gene","volume":"26","author":"Takada K","year":"2023","unstructured":"Takada K, Ueda MT, Shichinohe S, et al.. Genomic diversity of SARS-CoV-2 can be accelerated by mutations in the nsp14 gene. iScience. 2023, 26:106210. 10.1016\/j.isci.2023.106210","journal-title":"iScience"},{"key":"ref119","doi-asserted-by":"publisher","DOI":"10.7717\/PEERJ.10181\/SUPP-1","article-title":"Mutations of SARS-CoV-2 nsp14 exhibit strong association with increased genome-wide mutation load","volume":"8","author":"Eskier D","year":"2020","unstructured":"Eskier D, Suner A, Oktay Y, et al.. Mutations of SARS-CoV-2 nsp14 exhibit strong association with increased genome-wide mutation load. PeerJ. 2020, 8:10181. 10.7717\/PEERJ.10181\/SUPP-1","journal-title":"PeerJ"},{"key":"ref120","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2023.107899","article-title":"SARS-CoV-2 NSP14 governs mutational instability and assists in making new SARS-CoV-2 variants","volume":"170","author":"Hassan SS","year":"2024","unstructured":"Hassan SS, Bhattacharya T, Nawn D, et al.. SARS-CoV-2 NSP14 governs mutational instability and assists in making new SARS-CoV-2 variants. Comput Biol Med. 2024, 170:107899. 10.1016\/j.compbiomed.2023.107899","journal-title":"Comput Biol Med"},{"key":"ref121","doi-asserted-by":"publisher","DOI":"10.1128\/msphere.00726-24","article-title":"Combined mutations in nonstructural protein 14, envelope, and membrane proteins mitigate the neuropathogenicity of SARS-CoV-2 Omicron BA.1 in K18-hACE2 mice","volume":"10","author":"Sangare K","year":"2025","unstructured":"Sangare K, Liu S, Selvaraj P, Stauft CB, Starost MF, Wang TT. Combined mutations in nonstructural protein 14, envelope, and membrane proteins mitigate the neuropathogenicity of SARS-CoV-2 Omicron BA.1 in K18-hACE2 mice. mSphere. 2025, 10:e0072624. 10.1128\/msphere.00726-24","journal-title":"mSphere"},{"key":"ref122","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjid.2022.102677","article-title":"Sequencing and mutations analysis of the first recorded SARS-CoV-2 Omicron variant during the fourth wave of pandemic in Iraq","volume":"26","author":"Ahmed JQ","year":"2022","unstructured":"Ahmed JQ, Maulud SQ, Al-Qadi R, et al.. Sequencing and mutations analysis of the first recorded SARS-CoV-2 Omicron variant during the fourth wave of pandemic in Iraq. Braz J Infect Dis. 2022, 26:102677. 10.1016\/j.bjid.2022.102677","journal-title":"Braz J Infect Dis"},{"key":"ref123","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-023-00878-2","article-title":"The evolution of SARS-CoV-2","volume":"21","author":"Markov PV","year":"2023","unstructured":"Markov PV, Ghafari M, Beer M, Lythgoe K, Simmonds P, Stilianakis NI, Katzourakis A. The evolution of SARS-CoV-2. Nat Rev Microbiol. 2023, 21:361-79. 10.1038\/s41579-023-00878-2","journal-title":"Nat Rev Microbiol"},{"key":"ref124","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(23)00142-X","article-title":"Association of SARS-CoV-2 infection and persistence with long COVID","volume":"11","author":"Yang C","year":"2023","unstructured":"Yang C, Zhao H, Esp\u00edn E, Tebbutt SJ. Association of SARS-CoV-2 infection and persistence with long COVID. Lancet Respir Med. 2023, 11:504-6. 10.1016\/S2213-2600(23)00142-X","journal-title":"Lancet Respir Med"},{"key":"ref125","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00815-0","article-title":"Persistent SARS-CoV-2 infection: significance and implications","volume":"24","author":"Machkovech HM","year":"2024","unstructured":"Machkovech HM, Hahn AM, Garonzik Wang J, et al.. Persistent SARS-CoV-2 infection: significance and implications. Lancet Infect Dis. 2024, 24:453-62. 10.1016\/S1473-3099(23)00815-0","journal-title":"Lancet Infect Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/419368-what-has-sars-cov-2-taught-us-about-evolution","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T23:35:29Z","timestamp":1760398529000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/419368-what-has-sars-cov-2-taught-us-about-evolution"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,13]]},"references-count":125,"URL":"https:\/\/doi.org\/10.7759\/cureus.94502","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,13]]}}}